BPH Drugs Found to Decrease PSA Doubling Times

Share this content:

Men with prostate cancer on active surveillance (watchful waiting) may benefit from treatment with finasteride or dutasteride. John Schieszer reports in today's Medical Minute that taking a 5-alpha-reductase inhibitor may decrease PSA doubling time.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters